Multitarget drugs: the present and the future of cancer therapy
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14656560902781907
Reference87 articles.
1. The Hallmarks of Cancer
2. Receptor tyrosine kinases as targets for anticancer drugs
3. Signaling—2000 and Beyond
4. Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis
5. Comparing antibody and small-molecule therapies for cancer
Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Anticancer Phytochemicals of 21st Century: A Multitargeted Approach and Role of Humanism in Oncology;Alternative Remedies and Natural Products for Cancer Therapy: An Integrative Approach;2023-10-31
2. Would the Development of a Multitarget Inhibitor of 3CLpro and TMPRSS2 be Promising in the Fight Against SARS-CoV-2?;Medicinal Chemistry;2023-06
3. Small-Molecule Modulators Targeting Toll-like Receptors for Potential Anticancer Therapeutics;Journal of Medicinal Chemistry;2023-05-10
4. Targeted therapy for head and neck cancer: signaling pathways and clinical studies;Signal Transduction and Targeted Therapy;2023-01-16
5. Recent development of multi-targeted inhibitors of human topoisomerase II enzyme as potent cancer therapeutics;International Journal of Biological Macromolecules;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3